The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
Open accessAbstract
Achieving optimal outcomes in the treatment of hypertension--a prevalent and largely asymptomatic disease--necessitates that patients take their medications not only properly (medication adherence) but also continue to do so throughout long-term treatment (persistence). However, poor medication-taking behavior is a major problem among patients with hypertension, and has been identified as one of the main causes of failure to achieve adequate control of blood pressure (BP). In turn, patients with hypertension who have uncontrolled BP as a result of their poor medication-taking behavior remain at risk for serious morbidity and mortality (eg, stroke, myocardial infarction, and kidney failure), thereby accounting for a significant cost burden through avoidable hospital admissions, premature deaths, work absenteeism, and reduced productivity. Improving medication-taking behavior during antihypertensive therapy therefore represents an important potential source of health and economic improvement. Whereas many factors may contribute to poor medication-taking behavior, the complexity of dosage regimens and the side effect profiles of drugs probably have the greatest therapy-related influence. Central to any strategy aimed at improving outcomes for patients with hypertension, therefore, are efficacious antihypertensive agents that facilitate good medication-taking behavior through simplified dosing and placebo-like tolerability, along with the development of programs to detect poor medication adherence and to support long-term medication persistence in daily practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793
Wolf-Maier, K. (2003) · JAMA · doi:10.1001/jama.289.18.2363 · Cited by 1,737
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
How often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,021
Effectiveness of Interventions to Improve Patient Compliance: A Meta-Analysis
Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., & Svarstad, B. (1998) · Medical Care · doi:10.1097/00005650-199808000-00004 · Cited by 995
Inadequate Management of Blood Pressure in a Hypertensive Population
Berlowitz, D. R., Ash, A. S., Hickey, E. C., Friedman, R. H., Glickman, M., Kader, B., & Moskowitz, M. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392701 · Cited by 959
The meaning of medications: Another look at compliance
Conrad, P. (1985) · Social Science & Medicine · doi:10.1016/0277-9536(85)90308-9 · Cited by 818
DiMatteo, M. R., Sherbourne, C. D., Hays, R. D., & Ordway, L. (1993) · Health Psychology · doi:10.1037//0278-6133.12.2.93 · Cited by 812
Brian Haynes, R., Ann McKibbon, K., & Kanani, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01073-2 · Cited by 645
Patient compliance in hypertension: role of illness perceptions and treatment beliefs
Ross, S., Walker, A., & MacLeod, M. J. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001721 · Cited by 427
Schroeder, K., Fahey, T., & Ebrahim, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.722 · Cited by 416
Compliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.7.1509 · Cited by 405
Five-year blood pressure control and mortality following health education for hypertensive patients.
Morisky, D. E., Levine, D. M., Green, L. W., Shapiro, S., Russell, R. P., & Smith, C. R. (1983) · American Journal of Public Health · doi:10.2105/ajph.73.2.153 · Cited by 353
Persistence with treatment for hypertension in actual practice.
Jaime, J., Salas, M., Speckman, J. L., Raggio, G., & Jackson, J. D. (1999) · Europe PMC (PubMed Central) · Cited by 315
Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., & Ilersich, A. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85026-3 · Cited by 302
Continuation of initial antihypertensive medication after 1 year of therapy
Bloom, B. S. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80130-6 · Cited by 298
Psaty, B. M. (1990) · JAMA · doi:10.1001/jama.263.12.1653 · Cited by 268
Burnier, M., Schneider, M. P., Chioléro, A., Stubi, C. L. F., & Brunner, H. R. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00022 · Cited by 262
Self-citationPredictors of Uncontrolled Hypertension in Ambulatory Patients
Knight, E. L., Bohn, R. L., Wang, P. S., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · Hypertension · doi:10.1161/hy0901.091681 · Cited by 212
Compliance becomes concordance: Making a change in terminology produce a change in behaviour
Mullen, P. D. (1997) · BMJ · doi:10.1136/bmj.314.7082.691 · Cited by 194
The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population
McCombs, J. S., Nichol, M. B., Newman, C. M., & Sclar, D. A. (1994) · Medical Care · doi:10.1097/00005650-199403000-00003 · Cited by 187
van Eijken, M., Tsang, S., Wensing, M., de Smet, P. A. G. M., & Grol, R. P. T. M. (2003) · Drugs & Aging · doi:10.2165/00002512-200320030-00006 · Cited by 184 · cited 1×
“Multifaceted and tailored interventions appear to be the most effective methods of improving medication-taking behavior during antihypertensive therapy because they address the multiple factors associated with the problem.(57) However, these techniques tend to be complex, expensive, and laborintensive,(58) and they ar…”
Conlin, P. R., Gerth, W. C., Fox, J., Roehm, J. B., & Boccuzzi, S. J. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80152-1 · Cited by 184
Rizzo, J. A., & Robert Simons, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80018-5 · Cited by 174
Ogedegbe, G. G., Harrison, M., Robbins, L. P., Mancuso, C. A., & Allegrante, J. P. (2004) · PubMed · Cited by 174
Wetzels, G. E., Nelemans, P., Schouten, J. S., & Prins, M. H. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00002 · Cited by 172
Medical Care Expenditures for Hypertension, Its Complications, and Its Comorbidities
Hodgson, T. A., & Cai, L. (2001) · Medical Care · doi:10.1097/00005650-200106000-00008 · Cited by 172
Wolf-Maier, K., Cooper, R. S., & Banegas, J. R. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00271-x · Cited by 168
Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen
Roth, H. P., & Caron, H. S. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978233361 · Cited by 138
Antihypertensive persistence and drug class.
Marentette, M. A., Gerth, W. C., Billings, D. K., & Zarnke, K. B. (2002) · PubMed · Cited by 124
Impact of an Electronic Medication Compliance Aid on Long‐Term Blood Pressure Control
McKenney, J. M., Munroe, W. P., & Wright, J. T. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb03837.x · Cited by 121
Predicting compliance with a regimen of digoxin therapy in family practice.
Gilbert, J. R., Evans, C. E., Haynes, R. B., & Tugwell, P. (1980) · Europe PMC (PubMed Central) · Cited by 120
Nüesch, R., Schroeder, K., Dieterle, T., Martina, B., & Battegay, E. J. (2001) · BMJ · doi:10.1136/bmj.323.7305.142 · Cited by 120
Bourgault, C., Sénécal, M., Brisson, M., Marentette, M. A., & Grégoire, J. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001873 · Cited by 114
Sclar, D. A., Chin, A., Skaer, T. L., Okamoto, M. P., Nakahiro, R. K., & Gill, M. A. (1991) · PubMed · Cited by 113
A population-based European cohort study of persistence in newly diagnosed hypertensive patients
Hasford, J., Mimran, A., & Simons, W. R. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001451 · Cited by 108
Mar, J., & Rodríguez‐Artalejo, F. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00020 · Cited by 107
Monitoring one-year compliance to antihypertension medication in the Seychelles.
Bovet, P., Burnier, M., Madeleine, G., Waeber, B., & Paccaud, F. M. (2002) · Europe PMC (PubMed Central) · Cited by 100
Self-citationMatsui, D. M., Hermann, C., Klein, J., Berkovitch, M., Olivieri, N. F., & Koren, G. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb04009.x · Cited by 99
Helping Patients Follow Prescribed Treatment: Clinical Applications
Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002) · JAMA · doi:10.1001/jama.288.22.2880 · Cited by 98
Nurse-led adherence support in hypertension: a randomized controlled trial
Schroeder, K. (2005) · Family Practice · doi:10.1093/fampra/cmh717 · Cited by 96
Patient Adherence With Amlodipine, Lisinopril, or Valsartan Therapy in a Usual-Care Setting
Wogen, J., Krelick, C. A., Livornese, R. C., Yokoyama, K., & Frech, F. H. (2003) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2003.9.5.424 · Cited by 91
Monitoring compliance in resistant hypertension: an important step in patient management
Burnier, M., Santschi, V., Favrat, B., & Brunner, H. R. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305002-00007 · Cited by 90
Self-citationFixed-Dose Combination Antihypertensive Drugs
Sica, D. A. (1994) · Drugs · doi:10.2165/00003495-199448010-00003 · Cited by 82
Cramer, J. A. (1998) · PubMed · Cited by 78
Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice
Schwed, A., Stubi, C.-L. F., Burnier, M., Waeber, B., KAPPENBERGER, L. J., Burnand, B., & Darioli, R. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007976 · Cited by 78
Self-citationEffect of Perceived Barriers on Compliance with Antihypertensive Medication
Richardson, M. A., Simons‐Morton, B. G., & Annegers, J. F. (1993) · Health Education Quarterly · doi:10.1177/109019819302000409 · Cited by 68
Labour productivity effects of prescribed medicines for chronically ill workers
Rizzo, J. A., Abbott, T. A., & Pashko, S. (1996) · Health Economics · Cited by 63
IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY
Waeber, B., Vetter, W., Dariolp, R., Keller, U. B., & Hr, B. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11657.x · Cited by 50
Peltzer, K. (2004) · Curationis · doi:10.4102/curationis.v27i3.994 · Cited by 49
Burnier, M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00002 · Cited by 47
Self-citationWoollard, J., Burke, V., & Beilin, L. J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001593 · Cited by 46
Persistence with hypertension treatment among community-dwelling BC seniors.
Morgan, S. G., & Yan, L. (2004) · PubMed · Cited by 39
Burnier, M., Hess, B. J. M., Greminger, P., & Waeber, B. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-13 · Cited by 24
Self-citationBaune, B. T., Aljeesh, Y. I., & Bender, R. (2004) · Saudi Medical Journal · doi:10.15537/1658-3175.2665 · Cited by 16
Maryniuk, M. D., Bronzini, B. M., & Lorenzi, G. M. (2004) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170403000318 · Cited by 6
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Parati, G., Kjeldsen, S., Coca, A., Cushman, W. C., & Wang, J. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.15781 · Cited by 281
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
Metadata
- Authors
- BURNIER, M.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11
- Volume
- 19
- Issue
- 11
- Pages
- 1190-1196
- ISSN
- 0895-7061 (ISSN-L)
- OpenAlex
- W1971107382
- Cited by
- 358
- References
- 66
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.